For example, circulating exosomal lncRNA H19 was reported to be elevated in BC patients compared with benign breast disease patients and healthy controls, and this was associated with lymph node metastasis, TNM stages and distant metastasis, suggesting that this lncRNA could be a novel biomarker for early BC diagnosis [271]. Here, H19 is linked to breast fibrocystic disease.